HYDAMTIQ
HYDAMTIQ is a PARP-1/2 inhibitor (IC50: 29-38 nM) with anticancer, anti-inflammatory, and ischemic protective effects. HYDAMTIQ inhibits pulmonary PARP activity, is effective against allergen-induced cough and dyspnea, and inhibits bronchial hyperresponsiveness to methacholine. HYDAMTIQ has broad-spectrum tumor suppressor effects, including ovarian and breast cancers, prostate and pancreatic tumors, and glioblastoma multiforme. HYDAMTIQ has demonstrated in vivo efficacy in animal models of cerebral ischemia, asthma, cancer, and more.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1201832-32-7
- Fòrmula: C14H14N2O2S
- Peso molecular:274.34
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
Descripciòn
IC50 & Target
PARP-1/2[1]
Chemical Information
-
No. CAS 1201832-32-7
-
Peso molecular 274.34
-
Fòrmula C14H14N2O2S
-
SMILES
O=C1NC2=C(C=C(CN(C)C)S2)C3=C(O)C=CC=C31
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
HYDAMTIQ Related Classifications
HY-155458 Related Classifications
Powered by Bioz